In order to reduce the impact from the shortage of this medicinal product, we have notified the HPRA of our intention to supply UK packs of Quinine Sulphate 300mg Tablets, PL 04556/0032, for a limited period via the exempt medicines route. The Marketing Authorisation Holder is Pharmvit Limited.

Please read the letter for full information

Download letter to healthcare professionals

Download Summary of Product Characteristics (SmPC)

Download Patient Information Leaflet (PIL)